Pleural Effusion, Malignant: Clinical Trials

8 trials for Pleural Effusion, Malignant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 38Completed 8

Follow Pleural Effusion, Malignant: new trials by email Literature Review of Pleural Effusion, Malignant trials Research Report on Pleural Effusion, Malignant

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion
Iodopovidone solution, Talc - Malignant Pleural Effusion
Phase 3CompletedChiang Mai University602015-11-012020-01-23
Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients
Abnoba Viscum F 20mg - Malignant Pleural Effusion
Phase 3CompletedAbnoba Korea682011-01-012014-07-23
Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
Bevacizumab, Cisplatin - Malignant Pleural Effusion
Phase 3CompletedChinese PLA General Hospital722009-08-012015-03-25
A Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural Effusions
Thoracoscopy and Pleurx, Thoracoscopy - Malignant Pleural Effusions
Phase 3CompletedSingapore General Hospital1202008-09-012017-02-10
Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
talc, therapeutic thoracoscopy, therapeutic videothoracoscopy - Malignant Mesothelioma, Metastatic Cancer
Phase 3CompletedPapworth Hospital NHS Foundation Trust1962003-09-012013-06-28
Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer
talc, dyspnea management - Metastatic Cancer, Pulmonary Complications
Phase 3CompletedAlliance for Clinical Trials in Oncology672002-05-012016-07-04
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
bleomycin sulfate, doxycycline, talc - Metastatic Cancer
Phase 3CompletedEastern Cooperative Oncology Group4801997-01-102023-06-22
Talc in Treating Patients With Malignant Pleural Effusion
talc, Talc - Metastatic Cancer
Phase 3CompletedAlliance for Clinical Trials in Oncology5011994-12-012016-06-28

Narrower conditions

Neoplasm Metastasis (4)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Mesothelioma, Malignant (1)  ·  Solitary Fibrous Tumor, Pleural (1)

Broader conditions

Neoplasms (8)  ·  Neoplasms by Site (8)  ·  Pleural Diseases (8)  ·  Pleural Effusion (8)  ·  Pleural Neoplasms (8)  ·  Respiratory Tract Diseases (8)  ·  Respiratory Tract Neoplasms (8)  ·  Thoracic Neoplasms (8)  ·  Neoplastic Processes (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Lung Diseases (2)  ·  Lung Neoplasms (2)  ·  Adenoma (1)  ·  Bronchial Neoplasms (1)

Interventions

Talc (5)  ·  Bevacizumab (1)  ·  Bleomycin (1)  ·  Cisplatin (1)  ·  Doxycycline (1)  ·  Povidone-Iodine (1)  ·  Thoracoscopy (1)  ·  viscum album peptide (1)

Sponsors

Alliance for Clinical Trials in Oncology (2)  ·  Abnoba Korea (1)  ·  Chiang Mai University (1)  ·  Chinese PLA General Hospital (1)  ·  Eastern Cooperative Oncology Group (1)  ·  Papworth Hospital NHS Foundation Trust (1)  ·  Singapore General Hospital (1)

Countries

United States (2)  ·  Canada (1)  ·  China (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Apichat Tantraworasin (1)  ·  Devanand Anantham, FCCP (1)  ·  Friedemann Schad, MD (1)  ·  Jemi Olak, MD (1)  ·  John C. Ruckdeschel, MD (1)  ·  Kook Joo Na, MD (1)  ·  Nan Du (1)  ·  Randolph S. Marks, MD (1)  ·  Robert Winter, MD (1)  ·  Todd Demmy, MD (1)  ·  Yeong Dae Kim, MD (1)  ·  YongJik Lee, MD (1)

Results publications

PMID 15764775, PMID 14973997, PMID 16478853, PMID 17567670, PMID 24942631

NIH funding

U10CA031946 (1), U10CA076001 (1)